Holen Sie sich die Stockscreener-App
0.00
100.00%
-104.91
Exact Sciences Corp Aktie (EXAS) Neueste Nachrichten
EXAS Technical Analysis & Stock Price Forecast - Intellectia AI
Exact Sciences Corp. stock: Acquired by Abbott – What it means for you now - AD HOC NEWS
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Exact Sciences Completes Enrollment of DeeP-C Clinical Trial for Colorectal Cancer Screening - yahoo.com
Exact Sciences Stock: Is The Post-Earnings Slide A Buying Setup for 2026? - AD HOC NEWS
Select Health Care Portfolio's Exact Sciences Corp(EXAS) Holding History - GuruFocus
Exact Sciences (NASDAQ: EXAS) files Form 15 to suspend certain SEC reporting duties - Stock Titan
Exact Sciences Corp (EXK.DU) stock price, news, quote and history - Yahoo Finance UK
Excelerate Energy Stock: Leading Provider of LNG Infrastructure Faces Evolving Global Energy Demands - AD HOC NEWS
EXAS PE Ratio & Valuation, Is EXAS Overvalued - Intellectia AI
Cinctive Capital Management LP's Exact Sciences Corp(EXAS) Holding History - GuruFocus
Vanguard disaggregates holdings; Exact Sciences (NASDAQ: EXAS) shows 0 shares - Stock Titan
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences - Insider Monkey
Exact Sciences Corp. stock faces renewed scrutiny amid biotech sector volatility and pipeline update - AD HOC NEWS
Privia Health screening program increases colorectal cancer screening rates - MSN
Abbott (ABT) Stock Completes $21B Exact Sciences (EXAS) Acquisition - CoinCentral
Abbott closes $23 billion deal to buy Madison-based Exact Sciences - Yahoo Finance
EXAS Receives Neutral Rating from BTIG's Mark Massaro | EXAS Sto - GuruFocus
Abbott completes Exact Sciences acquisition - MassDevice
Key facts: Abbott Buys Exact Sciences; Notes Settle $105; Nasdaq Delist - tradingview.com
Exact Sciences Corp stock delisted from Nasdaq after $21 billion Abbott acquisition completion - AD HOC NEWS
Abbott Acquires Exact Sciences to Lead Cancer Screening and Diagnostics Market - Minichart
Exact Sciences Corp (EXAS) Files 8-K Announcing Material Agreements, Amendments, and Supplemental Indentures – March 2026 - Minichart
Abbott completes acquisition of Exact Sciences By Investing.com - Investing.com Canada
Exact Sciences Corp. stock delisted from Nasdaq after $21 billion Abbott acquisition completion - AD HOC NEWS
Abbott completes acquisition of Exact Sciences - Investing.com
Abbott completes $21 billion acquisition of Exact Sciences, delisting EXAS from Nasdaq - Investing.com
Exact Sciences (EXAS) director has equity cancelled and cashed out at $105 per share in Abbott merger - Stock Titan
Abbott’s buyout of Exact Sciences (EXAS) cashes out director’s shares - stocktitan.net
Abbott buys Exact Sciences (NASDAQ: EXAS) in $105-per-share cash merger - Stock Titan
Abbott buyout sees Exact Sciences (EXAS) director surrender all shares - Stock Titan
Abbott Acquires Exact Sciences, Strengthening Leadership in Cancer Screening - intellectia.ai
Exact Sciences Amends Convertible Notes; Post-Merger Conversions Payable in Cash at $105 Per Share - TradingView
Abbott buys Exact Sciences (NASDAQ: EXAS) in $21B cash deal - Stock Titan
Abbott (NYSE: ABT) closes Exact Sciences cancer diagnostics deal - Stock Titan
Exact Sciences Announced Transfer or Voluntary Withdrawal of Listing - TradingView
Exact Sciences Corp. stock faces analyst scrutiny amid moderate buy consensus and growth challenges - AD HOC NEWS
Exact Sciences Corporation (EXAS) Stock Price, News, Quote & History - Yahoo! Finance Canada
How Walgreens’ Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story - Yahoo Finance
The Bull Case For Exact Sciences (EXAS) Could Change Following Walgreens’ Nationwide Cologuard Pharmacy Rollout - simplywall.st
Abbott to close Exact Sciences acquisition on March 23 By Investing.com - Investing.com South Africa
Abbott (NYSE:ABT) Expands Diagnostics With Exact Sciences Amid S&P 500 Futures - Kalkine Media
Exact Sciences and Abbott receive all approvals for planned merger By Investing.com - Investing.com India
Abbott Laboratories to close $21B Exact Sciences deal Monday - Modern Healthcare News
When Abbott Labs expects to close on $23B takeover of Exact Sciences - The Business Journals
Exact Sciences Corp Announces Merger Agreement with Abbott Laboratories – SEC 8-K Filing March 2026 - minichart.com.sg
Abbott to close $21B Exact Sciences acquisition Monday - MedTech Dive
Abbott to close Exact Sciences acquisition on march 23 - Investing.com
Abbott to close Exact Sciences acquisition on March 23 - investing.com
Exact Sciences and Abbott receive all approvals for planned merger - Investing.com
Exact Sciences Nears Completion of Abbott Acquisition Deal - TipRanks
Exact Sciences stock hits 52-week high at $104.93 - Investing.com
Exact Sciences to be acquired by Abbott after receiving all regulatory approvals; closing anticipated March 23, 2026 - TradingView
Exact Sciences (NASDAQ: EXAS) secures approvals as Abbott merger targets March 23 close - Stock Titan
Cancer test maker Exact Sciences is set to join Abbott March 23 - Stock Titan
Piper Sandler Maintains Exact Sciences (EXAS) Overweight Recommendation - MSN
Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics - simplywall.st
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now - The Motley Fool
Exact Sciences Develops Home Colon Cancer Test Kit [da9403] - Fathom Journal
Health care again among the state’s biggest M&A deals of the past year - biztimes.com
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):